SCHEMBL1370542

SCHEMBL1370542

Cc1ccc(S(=O)(=O)C(C)C)cc1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.38
TDP1 Q9NUW8 1/20 0.38
CA2 P00918 4/20 0.37
CA1 P00915 3/20 0.37
CA9 Q16790 3/20 0.37
CA12 O43570 2/20 0.37
CA6 P23280 2/20 0.37
CA5A P35218 2/20 0.37
CA7 P43166 2/20 0.37
CA5B Q9Y2D0 2/20 0.37
CA4 P22748 1/20 0.37
CA14 Q9ULX7 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
HTR7 P34969 1/20 0.35
EPAS1 Q99814 1/20 0.35
HPGD P15428 4/20 0.34
ABL1 P00519 1/20 0.33
CA3 P07451 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12180488 0.82 LMNA (0.57) LMNATDP1PTGDR2L3MBTL1MEN1
SCHEMBL19748768 0.80 CA1 (0.41) LMNATDP1CA2CA1CA9
SCHEMBL6782609 0.79 ALDH1A1 (0.48) LMNATDP1CA2CA1CA9
SCHEMBL1369591 0.79 ALDH1A1 (0.41) LMNACA2CA1CA9CA12
SCHEMBL1370049 0.79 PSEN1 (0.41) CA2CA1CA9CA12CA6
SCHEMBL30098266 0.78 PTGS2 (0.42) LMNATDP1CA2CA1CA9
SCHEMBL2586501 0.78 PTGS2 (0.42) LMNATDP1CA2CA1CA9
SCHEMBL1368195 0.78 CA2 (0.61) LMNACA2CA1CA9CA12
SCHEMBL31402607 0.78 LMNA (0.42) LMNATDP1CA2CA1CA9
SCHEMBL24176361 0.77 LMNA (0.38) LMNATDP1PTGDR2L3MBTL1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273769-B2 Phenoxy acetic acid derivatives MERCK SERONO SA (CH) 2012-09-25 US disclosed
US-8273769-B2 Phenoxy acetic acid derivatives MERCK SERONO SA (CH) 2012-09-25 US disclosed
US-8273769-B2 Phenoxy acetic acid derivatives MERCK SERONO SA (CH) 2012-09-25 US disclosed
EP-2396295-A1 PHENOXY ACETIC ACID DERIVATIVES Merck Serono S.A. (CH) 2011-12-21 EP disclosed
US-20110288066-A1 PHENOXY ACETIC ACID DERIVATIVES MERCK SERONO S.A. (CH) 2011-11-24 US disclosed
US-20110288066-A1 PHENOXY ACETIC ACID DERIVATIVES MERCK SERONO S.A. (CH) 2011-11-24 US disclosed
US-20110288066-A1 PHENOXY ACETIC ACID DERIVATIVES MERCK SERONO S.A. (CH) 2011-11-24 US disclosed
WO-2010092043-A1 PHENOXY ACETIC ACID DERIVATIVES MERCK SERONO S.A. (CH) 2010-08-19 WO disclosed
WO-2010092043-A1 PHENOXY ACETIC ACID DERIVATIVES MERCK SERONO S.A. (CH) 2010-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110288066-A1 PHENOXY ACETIC ACID DERIVATIVES HRH2, HRH1, HRH3 LMNA 4243/4885TDP1 4632/4885CA2 804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.